NewsRoom Articles - Page 53 of 154 - PsychedelicNewsWire (PNW)

MondayJul 25, 2022 11:15 am

Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study

Silo Pharma produced initial batch of SPU-21 liposomes for rheumatoid arthritis study conducted by CRO Frontage Laboratories Recent company research revealed SPU-21 liposomes can target inflamed epithelium, suggesting use for targeted drug delivery SPU-21 can be used for development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis Company recently announced positive results in subcutaneous delivery of novel liposomes vs. intravenous injection Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company that focuses on fusing traditional therapeutics with psychedelic research, recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage…

MondayJul 25, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study

Data from newly acquired study could accelerate clinical development of CYBN’s CYB004 by nine months The pivotal study was designed with four primary objectives Cybin’s proprietary substance has potential to effectively treat anxiety disorders, including GAD and SAD Cybin (NEO: CYBN) (NYSE American: CYBN) has completed the acquisition of the largest dimethyltryptamine (“DMT”) study to date, a Phase 1 N,N-DMT study that provides key data relating to the company’s proprietary CYB004 substance (https://ibn.fm/2Ab0T). Information from the study is expected to help the company accelerate by up to nine months its clinical development pathway of CYB004. “With the closing of this transaction…

FridayJul 22, 2022 1:02 pm

A Review of Docuseries “How to Change Your Mind”

Last month, Netflix released the trailer for a docuseries called “How to Change Your Mind,” which was adapted from Michael Pollan’s book on the science of psychedelics and what it could teach us about depression, addiction, dying, consciousness and transcendence. Based on Pollan’s experiences and experiments with psychedelics, the docuseries was broken down into four 50-minute episodes with each focusing on a different psychedelic drug. The first episode discusses LSD while subsequent episodes cover psilocybin, MDMA and mescaline respectively. For plenty of people, Netflix’s new docuseries is the first time they are exposed to the growing world of psychedelic-assisted treatments.…

ThursdayJul 21, 2022 12:06 pm

Study Says Ayahuasca Users Tend to Exercise More, Eat Healthier

A new study has found that individuals who regularly use ayahuasca engage in a range of positive health behaviors that result in mental and physical health benefits. Ayahuasca is an entheogenic and psychedelic mixed brew that was traditionally used by the ancient Amazonian tribes in South America during religious ceremonies. In recent times, however, the brew has become popular due to its hallucinogenic effects and mental health benefits. Jose Carlos Bouso, the author of the study, stated that despite the growing popularity of the substances, some nations were prosecuting the use of ayahuasca. The study’s objective was to look into…

WednesdayJul 20, 2022 11:52 am

House Approves Amendments on Psychedelic Therapy in Defense Spending Measure

Research from recent years has revealed that psychedelic drugs have the potential to revolutionize mental health treatment. Psychedelics are federally classified as Schedule I drugs with no medical potential, however, making it nigh impossible for the people who would benefit from psychedelic treatments to access them. Fortunately, this may soon change after the U.S. House of Representatives passed psychedelic therapy amendments that would expand research into the benefits of psychedelics and allow veterans to access psychedelic-assisted PTSD treatments. The bipartisan amendments by Reps. Alexandria Ocasio-Cortez and Dan Crenshaw would increase access to psychedelics treatments for military veterans as well as…

TuesdayJul 19, 2022 1:04 pm

The DEA Could Be Sued Again Over Stance on Psilocybin, Cancer Patients

More than a year ago, a Seattle doctor and several cancer patients sued the U.S. Drug Enforcement Administration after the federal agency sent a letter declaring that the patients could not access synthetic psilocybin under federal and state right-to-try laws. These legislations grant patients with terminal illnesses the right to use experimental drugs that haven’t yet been approved for public use. The U.S. Court of Appeals for the Ninth Circuit dismissed the suit in February, stating that it did not have jurisdiction because the letter sent by the DEA wasn’t a final rule. However, the DEA could soon be sued…

MondayJul 18, 2022 12:19 pm

Experts Recommend Thinking Long Term When Investing in Psychedelics

We have seen the psychedelic industry grow significantly the last few years as investing companies pour more money into the burgeoning space and organizations respond to the global mental disorder epidemic. A Lancet study found that the worldwide pandemic has impacted individuals’ mental health significantly, with data showing that more than 75 million instances of anxiety disorders and more than 53 million additional major depressive disorder cases have been recorded. In the United States, the psychedelics industry is advancing rapidly after states such as California, Texas, New Jersey, Connecticut, Missouri and Utah made strides to legalize or decriminalize psychedelic drugs.…

FridayJul 15, 2022 11:32 am

Study Finds That Microdosing Psilocybin Mushrooms Improves Mood, Mental Health

New research has found evidence suggesting that magic mushrooms can improve the mood and mental health of an individual. The study analyzed about 1,100 subjects, with baseline evaluations being carried out at the start of the study then again between three or five weeks later. For their research, investigators analyzed the results of psilocybin microdoses combined with vitamin-B3 (niacin) or lion’s mane mushrooms. The researchers’ objective was to identify any improvement in mental health and mood that was consistent across presence of mental health concerns, age and gender as well as improvements in psychomotor performance, which were specific to older…

ThursdayJul 14, 2022 12:26 pm

Is It Safe to Smoke DMT?

DMT is said to be one of the most potent hallucinogens known to man. Smoking this drug, which is also called the spirit molecule, can cause a range of hallucinations, including visions of alien landscapes, temples, clowns, fairies, sprites, elves and goddesses. Nick Sand, an underground chemist, discovered in the 1960s that DMT was hallucinogenic when smoked, noting that what the drug opened humans up to was profound. In the 1990s, the drug’s reputation was changed when Terence McKenna, a psychedelic philosopher and author, lectured audiences about the drug’s hyperspaces. This was soon followed by a book on DMT, which…

WednesdayJul 13, 2022 3:48 pm

States That Have Made Advancements Toward Legalizing Psychedelics

Interest in psychedelics has grown significantly as mainstream acceptance grows and research uncovers more of the benefits that these substances possess, including how they can be used to manage a range of mental health disorders. These positive advancements have even led some states to decriminalize these controlled substances, with other states set to legalize the substances in the near future. Let’s look at some of the states that may soon legalize psychedelics. Oregon In November 2020, the state of Oregon passed a measure that would establish legal psychedelic healing centers where individuals aged 21 and above could undergo psilocybin-assisted therapy.…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000